Absci is trading at $9.46 (+7.07%) after opening-market strength on August 25, 2026, with the move primarily supported by biotechnology-sector momentum.
- No confirmed company-specific announcement was identified for August 25, 2026.
- XBI rose 2.06% during regular trading.
- Broader risk-on sentiment also provided support: Nasdaq up 0.84% and S&P 500 up 0.38%.